Achieve Life Sciences, Inc. Cash Equivalents, at Carrying Value
Achieve Life Sciences, Inc. (ACHV) had Cash Equivalents, at Carrying Value of $18.28 million as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-03-24
- 2025-12-31: Cash Equivalents, at Carrying Value $18.28M.
- 2025-09-30: Cash Equivalents, at Carrying Value $31.45M.
- 2025-06-30: Cash Equivalents, at Carrying Value $51.18M.
- 2025-03-31: Cash Equivalents, at Carrying Value $12.40M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $18.28M 10-K · filed 2026-03-24 |
| 2025-09-30 | $31.45M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $51.18M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $12.40M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $12.13M 10-K · filed 2026-03-24 |
| 2024-09-30 | $9.26M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $14.47M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $64.93M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $14.25M 10-K · filed 2025-03-11 |
| 2023-09-30 | $17.92M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $23.27M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $12.76M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $22.76M 10-K · filed 2024-03-28 |
| 2022-09-30 | $15.46M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $27.98M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $34.16M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $41.86M 10-K · filed 2023-03-16 |
| 2021-09-30 | $23.51M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $41.29M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $29.14M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $35.38M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |